EMILY BARKER: Open Payments
NPI 1215306196 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 34 payments from 9 companies in 2025. Trend: 2023 $533 · 2024 $896 · 2025 $801
Food & beverage: $711Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $298 |
| Lilly USA, LLC | 9 | $149 |
| Incyte Corporation | 5 | $124 |
| Novo Nordisk Inc | 3 | $81 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| PFIZER INC. | 1 | $36 |
| Dexcom, Inc. | 1 | $23 |
| ViiV Healthcare Company | 1 | $18 |
| Cleerly, Inc. | 1 | $14 |
Products named: TREMFYA, OPZELURA, EBGLYSS, TRELEGY ELLIPTA, Ozempic, PREVNAR 20, Wegovy, JARDIANCE.
Industry payments across CA — which companies pay providers there.
